NCT02342704 · Interventional trial
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
Overall registry status Terminated
Phase 4
Conditions Relapsing-Remitting Multiple Sclerosis
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory